Pulmonary tuberculosis. Respiratory tuberculosis, bacteriologically and histologically confirmed
Conditions
Interventions
Intervention 1: Treatment intervention will be conducted by using zinc sulfate syrup (250 mg dosage) (Iran Daroo company) which will be taken once a day (after dinner) for six months. Intervention 2:
Treatment - Drugs
Placebo
Treatment intervention will be conducted by using zinc sulfate syrup (250 mg dosage) (Iran Daroo company) which will be taken once a day (after dinner) for six months
and intervention with placebo will be conducted with placebo assumption once a day (after dinner) for six months.
Sponsors
Zabol University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
10 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All tuberculosis diagnosed patients with the age ranged between 10-60 years. Exclusion criteria: Any chromosomal disorders; allergy to zinc; chronic renal disease; any other supplement or placebo assumption; side effect appearance such as blurred vision, pulmonary edema, icter and severe gastrointestinal symptoms.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sputum smear. Timepoint: Beginning of diagnosis and two months, four months and six months after diagnosis. Method of measurement: Sputum smear. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum zinc level. Timepoint: Beginning of diagnosis and two months, four months and six months after diagnosis. Method of measurement: Serum zinc level in micrograms per liter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDonya Arefi
Zabol University of Medical Sciences
Outcome results
None listed